[Status of the therapy of multiple sclerosis].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002328:Carisoprodol / Q000627:therapeutic use; D003604:Czechoslovakia; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000534:rehabilitation / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011427:Propiophenones / Q000627:therapeutic use; D012146:Rest; D014665:Vasodilator Agents / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use
D000927:Anticonvulsants; D009125:Muscle Relaxants, Central; D010880:Piperidines; D011427:Propiophenones; D014665:Vasodilator Agents; D014803:Vitamin B Complex; D002328:Carisoprodol; D000324:Adrenocorticotropic Hormone; D014805:Vitamin B 12
Zum Stand der Therapie der Multiplen Sklerose.